Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer “Toolkit” Proposal Focuses On Adverse Event Signals

Executive Summary

Pfizer is proposing that the PhRMA/FDA "toolkit" working group focus on methods to gather more reliable signals of adverse events as a precursor to an improved risk management system

You may also be interested in...



Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs

The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting

Rx Risk Descriptions Need To Be Standardized, FDA’s Galson Tells CERTs

The standardization of risk expressions to compare drugs would be a desirable risk management tool, Center for Drug Evaluation & Research Deputy Director Steven Galson, MD, suggested at a recent CERTs meeting

Lilly Forteo Risk Management Program Limits Launch To 8,000 Doctors

Lilly's launch of Forteo will be focused on 8,000 physicians identified by the company as specializing in severe osteoporosis

Related Content

UsernamePublicRestriction

Register

PS039022

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel